Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Pharma-Bio Serv, Inc.

PBSV OTC SEC CIK 1304161
Follow Pharma-Bio Serv Weekly email: filings, results, news

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $2.3M +19% vs same quarter last year
Net income −$14.2K +93% vs same quarter last year
EPS, diluted −$0.00 +88.9% vs same quarter last year
Operating cash flow $60.9K −74.3% vs same quarter last year
Revenue by quarter
$2.3M
$2.5M
$2.4M
$2M
$2.1M
$2.3M
$2.7M
$2.3M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$10M$0$10M$20M$30MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$9M−$100.5K
FY24$9.5M−$777.6K
FY23$17M$1.3M
FY22$19.4M$1M
FY21$20.1M−$2.1M
FY20$21.6M$2.1M
FY19$19.5M$2.1M
FY18$17.8M$1.3M
FY17$13.3M−$1.4M
FY16-−$256.6K
FY15-$1.6M
FY14-$2.4M
FY13-$4.9M
FY12-$4.7M
FY11-$3.2M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−20%0%20%40%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2532.3%−7.1%−1.1%
FY2426.5%−13.5%−8.2%
FY2329.8%6.6%7.7%
FY2225.2%6.1%5.2%
FY2126.6%−19.2%−10.4%
FY2030.9%10.3%9.5%
FY1931.7%8.7%10.7%
FY1832%−7.1%7.2%
FY1728.9%−5.8%−10.6%
FY16---
FY15---
FY14---
FY13---
FY12---
FY11---
Free cash flowOperating cash flow minus capital expenditure
−$4M−$2M$0$2M$4M$6MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$221.5K
FY24−$726.4K
FY23$1.9M
FY22$573.2K
FY21$794K
FY20$1.5M
FY19−$2.3M
FY18$3.6M
FY17−$979.6K
FY16−$1.1M
FY15$30.2K
FY14$3.1M
FY13$5.4M
FY12$2.3M
FY11$2M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$1M$2M$3M$4MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$1.7M$31.4K
FY24$1.7M$11.3K
FY23$1.7M$34.3K
FY22$3.4M$82K
FY21$1.7M$26K
FY20$1.7M$1.7K
FY19$0$87.9K
FY18-$56.5K
FY17-$15.4K
FY16-$45.9K
FY15-$168.7K
FY14-$18.1K
FY13--
FY12--
FY11--
Net margin vs the sectorMedian of Industrials companies filing with the SEC
  • Pharma-Bio Serv
  • Industrials median
−20%−10%0%10%20%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearPharma-Bio ServIndustrials median
FY25−1.1%6.9%
FY24−8.2%6.1%
FY237.7%6.4%
FY225.2%7.2%
FY21−10.4%6.9%
FY209.5%4.5%
FY1910.7%5.9%
FY187.2%5.8%
FY17−10.6%6.3%
FY16-5%
FY15-4.4%
FY14-5.6%
FY13-6.3%
FY12-6.2%
FY11-5.4%

News

No stories filed under Pharma-Bio Serv yet - coverage appears here as the news feed clusters it.